Company Overview and News
The following slide deck was published by Benitec Biopharma Ltd ADR in conjunction with this event.
We discuss Bausch and Lomb’s India sales, and whether that has any bearing on Valeant’s woes. (486-1)
Benitec Biopharma Ltd’s (ASX:BLT) shares closed 20% higher on Wednesday after securing a new patent related to its hepatitis B program in the U.S.
If you want a Stock Review on BDSI, BLRX, BNTC or SNGX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has initiated coverage on BioDelivery Sciences International Inc. (NASDAQ: BDSI), BioLine Rx Ltd (NASDAQ: BLRX), Benitec Biopharma Ltd (NASDAQ: BNTC), and Soligenix Inc. (NASDAQ: SNGX). These equities operate in the Biotech space, which consists of companies engaged in the research and development of new drugs, medical devices, and procedures.
WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017. (0-1)
Thank you for standing by and welcome to the Benitec Biopharma Quarterly Corporate Update Conference Call.
On Tuesday, April 25, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, Stock-Callers.com assessed the following Biotechnology equities this morning: Cymabay Therapeutics Inc. (NASDAQ: CBAY), Benitec Biopharma Ltd (NASDAQ: BNTC), Sage Therapeutics Inc.
On Tuesday, April 25, 2017, US markets saw broad based gains with eight out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday's session. The NASDAQ Composite ended the day at 6,025.49, up 0.70%; the Dow Jones Industrial Average edged 1.12% higher, to finish at 20,996.12; and the S&P 500 closed at 2,388.61, up 0.61%. This Wednesday morning, Stock-Callers.
Redx Pharma, the research and development company focused on cancer, immunology and infection, announces that it has appointed Mr Iain Ross as Chairman of its Board of Directors and as a Non-Executive Director of the Company, effective from 1st May 2017.
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
LONDON, April 4 Global investment banking fees reached a 10-year high in the first quarter of 2017 with more than half of the $24 billion in total takings coming from North America, Thomson Reuters data showed on Tuesday.
* Solar Alliance Energy - as per loi, co will acquire seller's team of employees and acquire seller's pipeline of in-process residential solar projects
* Benitec Biopharma Ltd - key pre-clinical data on oculopharyngeal muscular dystrophy (opmd) published in nature communications
Benitec Biopharma (ASX:BLT) has received a $5.59 million cash refund under the Federal Government’s R&D Tax Incentive Scheme.
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.
2017-12-11 - Wilton
2017-12-11 - Wilton
2017-12-03 - Wilton
2017-11-27 - Wilton